The Two-Hit Model for Wilms' Tumor: Where Are We 30 Years Later?

Genes Chromosomes and Cancer

Volumn 38, Issue 4, 2003, Pages 294-299

  Strong, Louise C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEPHROBLASTOMA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIRIDIA; AUTOSOMAL DOMINANT DISORDER; BECKWITH WIEDEMANN SYNDROME; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL LINEAGE; CHILDHOOD CANCER; CHROMOSOME 11; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME ARM; CHROMOSOME DELETION; CYTOGENETICS; DISEASE ASSOCIATION; DNA TUMOR VIRUS; DYSGERMINOMA; FRASER SYNDROME; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; GONADAL DYSGENESIS; GONADOBLASTOMA; HEMIHYPERTROPHY; HETEROZYGOSITY LOSS; HUMAN; HUMAN GENETICS; HYPERPARATHYROIDISM; KARYOTYPE; KIDNEY DEVELOPMENT; KIDNEY FAILURE; MEDICAL GENETICS; MENTAL DEFICIENCY; MESOTHELIOMA; MOLECULAR GENETICS; NEPHROBLASTOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN INTERACTION; PSEUDOHERMAPHRODITISM; RETINOBLASTOMA; REVIEW; SOMATIC MUTATION; SURVIVAL; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED CARCINOMA; UROGENITAL TRACT MALFORMATION; WAGR SYNDROME; X CHROMOSOME; Y CHROMOSOME;

GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; MODELS, GENETIC; MOLECULAR BIOLOGY; WILMS TUMOR;

ANIMALIA;

EID: 0345707482     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10292     Document Type: Review

References (46)

1. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. 1997. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467-470.
2. Beales PL, Badano JL, Ross AJ, Ansley SJ, Hoskins BE, Kirsten B, Mein CA, Froguel P, Scambler PJ, Lewis RA, Lupski JR, Katsanis N. 2003. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet 72:1187-1199.
3. Bonaiti-Pellie C, Chompret A, Tournade MF, Lemerle J, Voute PA, Delemarre JF. 1993. Excess of multifocal tumors in nephroblastoma: Implications for mechanisms of tumor development and genetic counseling. Hum Genet 91:373-376.
4. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. 1995. Second malignant neoplasms following treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 13:1851-1859.
5. Breslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. 2000. Renal failure in the Denys-Drash and Wilms tumor-aniridia syndromes. Cancer Res 60:4030-4032.
6. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
7. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H III, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR. 2002, HRPT2, encoding parafibromin, is mutated in hyperparachyroidism-jaw tumor syndrome. Nat Genet 32:676-680.
8. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. 1983. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784.
9. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire JA, Phillips RA, Gallie BL. 1985. Genetic origin of mutations predisposing to retinoblastoma. Science 228:501-503.
10. Chau BN, Wang JY. 2003. Coordinated regulation of life and death by RB. Nat Rev Cancer 3:130-138.
11. Classon M, Harlow E. 2002. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917.
12. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
13. Dyson N, Howley PM, Munger K, Harlow E. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
14. Fearon ER, Vogelstein B, Feinberg AP. 1984. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 309:176-178.
15. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646.
16. Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE. 2002. Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 20:2506-2513.
17. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK. 1988. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 336:374-376.
18. Henneveld HT, van Lingen RA, Hamel BC, Stolte-Dijkstra I, van Essen AJ. 1999. Perlman syndrome: Four additional cases and review. Am J Med Genet 86:439-446.
19. Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF. 1988. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 336:377-337.
20. Huff V, Miwa H, Haber DA, Call KM, Housman DE, Strong LC, Saunders GF. 1991. Evidence for WT1 as a Wilms' tumor (WT) gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 48:997-1003.
21. Huff V, Jaffe N, Saunders GF, Strong LC, Villaba F, Ruteshouser EC. 1995. WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Am J Hum Genet 56:84-90.
22. Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA. 2000. Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst 92:2037-2039.
23. Knudson AG. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
24. Knudson AG Jr., Strong LC. 1972a. Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313-324.
25. Knudson AG Jr., Strong LC. 1972b. Mutation and cancer: Neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514-532.
26. Knudson AG Jr., Strong LC, Anderson DE. 1973. Heredity and cancer in man. Prog Med Genet 113-148.
27. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK. 1989. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
28. Li FP, Williams WR, Gimbrere K, Flamant F, Green DM, Meadows AT. 1988. Heritable fraction of unilateral Wilms tumor. Pediatrics 81:147-149.
29. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL. 1988. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41-48.
30. McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, Strong LC, Virshup D, Huff V. 1998. Linkage of familial Wilms' tumor predisposition to chromosome 19 and two-locus model for the etiology of familial tumors. Cancer Res 58:1387-1390.
31. Mulvihill JJ, Myers MH, Connelly RR, Byrne J, Austin DF, Bragg K, Cook JW, Hassinger DD, Holmes FF, Holmes GF, Krauss MR, Latourette HB, Meigs JW, Naughton MD, Steinhorn SC, Strong LC, Teta MJ, Weyer PJ. 1987. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 2:813-817.
32. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421.
33. Olson JM, Hamilton A, Breslow NE. 1995. Non-11p constitutional chromosome abnormalities in Wilms' tumor patients. Med Pediatr Oncol 24:305-309.
34. Patmasiriwat P, Fraizer G, Kantarjian H, Saunders GF. 1999. WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia. Leukemia 13:891-900.
35. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, Pritchard-Jones K, Stratton MR, Narod SA. 1996. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461-463.
36. Riccardi VM, Sujansky E, Smith, AC, Francke U. 1978. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 61:604-610.
37. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. 2003. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 72:253-269.
38. Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Moller T, Tulinius H. 1998. Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med 338:1339-1344.
39. Schroeder WT, Chao LY, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF. 1987. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 40:413-420.
40. Schubert EL, Strong LC, Hansen MF. 1997. A splicing mutation in RB1 in low penetrance retinoblastoma. Hum Genet 100:557-563.
41. Seemanova E, Bartsch O. 1999. Mulibrey nanism and Wilms tumor. Am J Hum Genet 85:76-78.
42. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. 1988. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129.
43. Wiedemann HR. 1983. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129.
44. Wilkins RJ. 1988. Genomic imprinting and carcinogenesis. Lancet 1:329-331.
45. Wong FL, Boice JD Jr., Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr., Li FP. 1997. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278:1262-1267.
46. Zhang Y, Shields T, Crenshak T, Hao Y, Moulton T, Tycko B. 1993. Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet 53:113-124.